Charles Schwab Investment Management Inc Spero Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 28,565 shares of SPRO stock, worth $26,851. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,565
Previous 28,565
-0.0%
Holding current value
$26,851
Previous $37,000
2.7%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SPRO
# of Institutions
49Shares Held
13.9MCall Options Held
200Put Options Held
200-
Anson Funds Management LP Dallas, TX3.75MShares$3.53 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.66 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.27 Million14.54% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$1.01 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny975KShares$916,1730.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $33M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...